Patrick JE - Search Results

1

Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects.

Patrick JE, Kosoglou T, Stauber KL, Alton KB, Maxwell SE, Zhu Y, Statkevich P, Iannucci R, Chowdhury S, Affrime M, Cayen MN. Patrick JE, et al. Drug Metab Dispos. 2002 Apr;30(4):430-7. doi: 10.1124/dmd.30.4.430. Drug Metab Dispos. 2002. PMID: 11901097 Clinical Trial.

2

Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin.

Kosoglou T, Meyer I, Veltri EP, Statkevich P, Yang B, Zhu Y, Mellars L, Maxwell SE, Patrick JE, Cutler DL, Batra VK, Affrime MB. Kosoglou T, et al. Among authors: patrick je. Br J Clin Pharmacol. 2002 Sep;54(3):309-19. doi: 10.1046/j.1365-2125.2002.01633.x. Br J Clin Pharmacol. 2002. PMID: 12236852 Free PMC article. Clinical Trial.

3

Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of posaconazole (Noxafil).

Ghosal A, Hapangama N, Yuan Y, Achanfuo-Yeboah J, Iannucci R, Chowdhury S, Alton K, Patrick JE, Zbaida S. Ghosal A, et al. Among authors: patrick je. Drug Metab Dispos. 2004 Feb;32(2):267-71. doi: 10.1124/dmd.32.2.267. Drug Metab Dispos. 2004. PMID: 14744950

4

Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia).

Ghosal A, Hapangama N, Yuan Y, Achanfuo-Yeboah J, Iannucci R, Chowdhury S, Alton K, Patrick JE, Zbaida S. Ghosal A, et al. Among authors: patrick je. Drug Metab Dispos. 2004 Mar;32(3):314-20. doi: 10.1124/dmd.32.3.314. Drug Metab Dispos. 2004. PMID: 14977865

5

Disposition of 14C-eptifibatide after intravenous administration to healthy men.

Alton KB, Kosoglou T, Baker S, Affrime MB, Cayen MN, Patrick JE. Alton KB, et al. Among authors: patrick je. Clin Ther. 1998 Mar-Apr;20(2):307-23. doi: 10.1016/s0149-2918(98)80094-5. Clin Ther. 1998. PMID: 9589822 Clinical Trial.

6

Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3-hydroxydesloratadine.

Ghosal A, Yuan Y, Hapangama N, Su AD, Alvarez N, Chowdhury SK, Alton KB, Patrick JE, Zbaida S. Ghosal A, et al. Among authors: patrick je. Biopharm Drug Dispos. 2004 Sep;25(6):243-52. doi: 10.1002/bdd.405. Biopharm Drug Dispos. 2004. PMID: 15334623

7

Metabolism and excretion of loratadine in male and female mice, rats and monkeys.

Ramanathan R, Alvarez N, Su AD, Chowdhury S, Alton K, Stauber K, Patrick J. Ramanathan R, et al. Xenobiotica. 2005 Feb;35(2):155-89. doi: 10.1080/00498250500038906. Xenobiotica. 2005. PMID: 16019945

8

The plasma concentration and LDL-C relationship in patients receiving ezetimibe.

Ezzet F, Wexler D, Statkevich P, Kosoglou T, Patrick J, Lipka L, Mellars L, Veltri E, Batra V. Ezzet F, et al. J Clin Pharmacol. 2001 Sep;41(9):943-9. doi: 10.1177/00912700122010915. J Clin Pharmacol. 2001. PMID: 11549098 Clinical Trial.

9

Fragmentation of N-oxides (deoxygenation) in atmospheric pressure ionization: investigation of the activation process.

Tong W, Chowdhury SK, Chen JC, Zhong R, Alton KB, Patrick JE. Tong W, et al. Among authors: patrick je. Rapid Commun Mass Spectrom. 2001;15(22):2085-90. doi: 10.1002/rcm.475. Rapid Commun Mass Spectrom. 2001. PMID: 11746872

10

Identification of human liver cytochrome P450 enzymes involved in the metabolism of SCH 351125, a CCR5 antagonist.

Ghosal A, Chowdhury SK, Gupta S, Yuan Y, Iannucci R, Zhang H, Zbaida S, Patrick JE, Alton KB. Ghosal A, et al. Among authors: patrick je. Xenobiotica. 2005 May;35(5):405-17. doi: 10.1080/00498250500136569. Xenobiotica. 2005. PMID: 16012074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters